A Mycobacterium bovis BCG-Naked DNA Prime-Boost Vaccination Strategy Induced CD4+ and CD8+ T-Cell Response against Mycobacterium tuberculosis Immunogens
Mycobacterium tuberculosis infection is still a major global public health problem. Presently the only tuberculosis (TB) vaccine available is Bacille Calmette-Guérin (BCG), although it fails to adequately protect against pulmonary TB in adults. To solve this problem, the development of a new effecti...
Saved in:
| Main Authors: | Miao Lu, Zhi Yang Xia, Lang Bao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2014/395626 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Determination of residual virulence and immunogenicity of Mycobacterium bovis BCG-1 seed lots
by: D. T. Levi, et al.
Published: (2018-02-01) -
CD8+ regulatory T cells, and not CD4+ T cells, dominate suppressive phenotype and function after in vitro live Mycobacterium bovis-BCG activation of human cells.
by: Mardi C Boer, et al.
Published: (2014-01-01) -
Phenotypic drug susceptibility testing for Mycobacterium tuberculosis variant bovis BCG in 12 hours
by: Buu Minh Tran, et al.
Published: (2025-05-01) -
Efficacy and immunogenicity of rKVAC85B in a BCG prime-boost regimen against H37Rv and HN878 Mycobacterium tuberculosis strains.
by: Eunkyung Shin, et al.
Published: (2025-01-01) -
High Mobility Group Box 1 Protein Induction by Mycobacterium Bovis BCG
by: Péter Hofner, et al.
Published: (2007-01-01)